• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙氨酸转氨酶和胆红素动态演变模式作为药物性肝损伤中急性肝衰竭预测的新模型

Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury.

作者信息

Yang Ruiyuan, Li Kexin, Zou Cailun, Wee Aileen, Liu Jimin, Liu Liwei, Li Min, Wu Ting, Wang Yu, Ma Zikun, Wang Yan, Liu Jingyi, Huang Ang, Sun Ying, Chang Binxia, Liang Qingsheng, Jia Jidong, Zou Zhengsheng, Zhao Xinyan

机构信息

Liver Research Center, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing, China.

Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.

出版信息

Front Pharmacol. 2022 Jul 22;13:934467. doi: 10.3389/fphar.2022.934467. eCollection 2022.

DOI:10.3389/fphar.2022.934467
PMID:35935831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9355525/
Abstract

To develop, optimize, and validate a novel model using alanine aminotransferase (ALT) and total bilirubin (TB) dynamic evolution patterns in predicting acute liver failure (ALF) in drug-induced liver injury (DILI) patients. The demographics, clinical data, liver biopsy, and outcomes of DILI patients were collected from two hospitals. According to the dynamic evolution of ALT and TB after DILI onset, the enrolled patients were divided into ALT-mono-peak, TB-mono-peak, double-overlap-peak, and double-separate-peak (DSP) patterns and compared. Logistic regression was used to develop this predictive model in both discovery and validation cohorts. The proportion of ALF was significantly higher in patients with the DSP pattern than in the ALT-mono-peak pattern and DOP pattern (10.0 vs. 0.0% vs. 1.8%, < 0.05). The area under receiver operating characteristic curve (AUROC) of the DSP pattern model was 0.720 (95% CI: 0.682-0.756) in the discovery cohort and 0.828 (95% CI: 0.788-0.864) in the validation cohort in predicting ALF, being further improved by combining with international normalized ratio (INR) and alkaline phosphatase (ALP) (AUROC in the discovery cohort: 0.899; validation cohort: 0.958). Histopathologically, patients with the DSP pattern exhibited a predominantly cholestatic hepatitis pattern (75.0%, < 0.05) with a higher degree of necrosis (29.2%, = 0.084). DILI patients with the DSP pattern are more likely to progress to ALF. The predictive potency of the model for ALF can be improved by incorporating INR and ALP. This novel model allows for better identification of high-risk DILI patients, enabling timely measures to be instituted for better outcome.

摘要

利用丙氨酸氨基转移酶(ALT)和总胆红素(TB)的动态演变模式开发、优化并验证一种预测药物性肝损伤(DILI)患者急性肝衰竭(ALF)的新模型。从两家医院收集DILI患者的人口统计学资料、临床数据、肝活检及预后情况。根据DILI发病后ALT和TB的动态演变,将纳入患者分为ALT单峰型、TB单峰型、双峰重叠型和双峰分离型(DSP)模式并进行比较。在发现队列和验证队列中均使用逻辑回归开发此预测模型。DSP模式患者中ALF的比例显著高于ALT单峰型模式和双峰重叠型模式患者(10.0% 对0.0% 对1.8%,P<0.05)。在预测ALF方面,DSP模式模型在发现队列中的受试者工作特征曲线下面积(AUROC)为0.720(95%可信区间:0.682 - 0.756),在验证队列中为0.828(95%可信区间:0.788 - 0.864),通过结合国际标准化比值(INR)和碱性磷酸酶(ALP)可进一步改善(发现队列中的AUROC:0.899;验证队列:0.958)。组织病理学上,DSP模式患者主要表现为胆汁淤积性肝炎模式(75.0%,P<0.05),坏死程度更高(29.2%,P = 0.084)。具有DSP模式的DILI患者更易进展为ALF。通过纳入INR和ALP可提高该模型对ALF的预测效力。这种新模型能够更好地识别高危DILI患者,从而能够及时采取措施以获得更好的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/8cc729ba653e/fphar-13-934467-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/e3bd06443a58/fphar-13-934467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/781e3bb676ab/fphar-13-934467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/64a10af9f123/fphar-13-934467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/063fec69946a/fphar-13-934467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/8cc729ba653e/fphar-13-934467-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/e3bd06443a58/fphar-13-934467-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/781e3bb676ab/fphar-13-934467-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/64a10af9f123/fphar-13-934467-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/063fec69946a/fphar-13-934467-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f14/9355525/8cc729ba653e/fphar-13-934467-g005.jpg

相似文献

1
Alanine Aminotransferase and Bilirubin Dynamic Evolution Pattern as a Novel Model for the Prediction of Acute Liver Failure in Drug-Induced Liver Injury.丙氨酸转氨酶和胆红素动态演变模式作为药物性肝损伤中急性肝衰竭预测的新模型
Front Pharmacol. 2022 Jul 22;13:934467. doi: 10.3389/fphar.2022.934467. eCollection 2022.
2
Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.应用 Hy's 法则和一种新的复合算法预测药物性肝损伤患者的急性肝衰竭。
Gastroenterology. 2014 Jul;147(1):109-118.e5. doi: 10.1053/j.gastro.2014.03.050. Epub 2014 Apr 1.
3
Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.药物性肝损伤患者急性肝衰竭的风险:海氏法则及一种新的预后模型评估
Clin Gastroenterol Hepatol. 2015 Dec;13(13):2360-8. doi: 10.1016/j.cgh.2015.06.020. Epub 2015 Jun 27.
4
Outcomes and Predictors of Mortality in Patients With Drug-Induced Liver Injury at a Tertiary Hospital in South India: A Single-Centre Experience.印度南部一家三级医院药物性肝损伤患者的死亡率结局及预测因素:单中心经验
J Clin Exp Hepatol. 2021 Mar-Apr;11(2):163-170. doi: 10.1016/j.jceh.2020.08.008. Epub 2020 Aug 20.
5
The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.印度药物性肝损伤网络:1288例患者的病因、临床特征、结局及预后标志物
J Clin Exp Hepatol. 2021 May-Jun;11(3):288-298. doi: 10.1016/j.jceh.2020.11.002. Epub 2020 Nov 17.
6
[An analysis on clinical characteristics and prognosis-related risk factors in patients with drug-induced liver injury].药物性肝损伤患者的临床特征及预后相关危险因素分析
Zhonghua Gan Zang Bing Za Zhi. 2024 Mar 20;32(3):214-221. doi: 10.3760/cma.j.cn501113-20240201-00072.
7
Development and validation of a novel model to predict liver-related mortality in patients with idiosyncratic drug-induced liver injury.开发并验证一种新模型,以预测特异质药物性肝损伤患者的肝相关死亡率。
Hepatobiliary Pancreat Dis Int. 2023 Dec;22(6):584-593. doi: 10.1016/j.hbpd.2023.06.002. Epub 2023 Jun 2.
8
Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.住院患者中显著升高的丙氨酸氨基转移酶与药物性肝损伤。
World J Gastroenterol. 2012 Nov 7;18(41):5972-8. doi: 10.3748/wjg.v18.i41.5972.
9
Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.269 例抗结核药物性肝损伤患者的转归及影响因素分析。
J Gastroenterol Hepatol. 2013 Jan;28(1):161-7. doi: 10.1111/j.1440-1746.2012.07279.x.
10
The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.血清天冬氨酸氨基转移酶和γ-谷氨酰转肽酶作为肝毒性生物标志物的价值。
Liver Int. 2015 Nov;35(11):2474-82. doi: 10.1111/liv.12834. Epub 2015 Apr 8.

引用本文的文献

1
A nomogram model based on routine serum markers for predicting the occurrence of primary cholangitis after Kasai operation for biliary atresia.一种基于常规血清标志物的列线图模型,用于预测胆道闭锁Kasai手术后原发性胆管炎的发生。
Transl Pediatr. 2025 Jun 27;14(6):1103-1116. doi: 10.21037/tp-2025-170. Epub 2025 Jun 25.
2
Application of physiological network mapping in the prediction of survival in critically ill patients with acute liver failure.生理网络映射在预测急性肝衰竭危重症患者生存中的应用。
Sci Rep. 2024 Oct 9;14(1):23571. doi: 10.1038/s41598-024-74351-2.

本文引用的文献

1
New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years.丙型肝炎病毒的新希望:20 多年来全球流行病学变化和新创新的总结。
World J Gastroenterol. 2021 Aug 7;27(29):4818-4830. doi: 10.3748/wjg.v27.i29.4818.
2
Consensus scoring systems for nonalcoholic fatty liver disease: an unmet clinical need.非酒精性脂肪性肝病的共识评分系统:一项未满足的临床需求。
Hepatobiliary Surg Nutr. 2021 Jun;10(3):388-390. doi: 10.21037/hbsn-21-80.
3
Approach to the patient with acute severe autoimmune hepatitis.
急性重症自身免疫性肝炎患者的诊疗方法
JHEP Rep. 2020 Jul 21;2(6):100149. doi: 10.1016/j.jhepr.2020.100149. eCollection 2020 Dec.
4
Recent advances in alcoholic hepatitis.酒精性肝炎的最新进展
F1000Res. 2020 Feb 10;9. doi: 10.12688/f1000research.20394.1. eCollection 2020.
5
Diagnostic and prognostic assessment of suspected drug-induced liver injury in clinical practice.疑似药物性肝损伤的临床诊断和预后评估。
Liver Int. 2020 Jan;40(1):6-17. doi: 10.1111/liv.14271. Epub 2019 Oct 14.
6
Acute liver failure.急性肝衰竭。
Lancet. 2019 Sep 7;394(10201):869-881. doi: 10.1016/S0140-6736(19)31894-X.
7
A proposed pathologic sub-classification of drug-induced liver injury.药物性肝损伤的病理亚型分类建议。
Hepatol Int. 2019 May;13(3):339-351. doi: 10.1007/s12072-019-09940-9. Epub 2019 Apr 11.
8
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.共识:指南:在临床试验中检测、评估和管理非酒精性脂肪性肝炎患者疑似急性药物性肝损伤的最佳实践。
Aliment Pharmacol Ther. 2019 Mar;49(6):702-713. doi: 10.1111/apt.15153. Epub 2019 Feb 13.
9
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.中国内地药物性肝损伤的发生率及病因学。
Gastroenterology. 2019 Jun;156(8):2230-2241.e11. doi: 10.1053/j.gastro.2019.02.002. Epub 2019 Feb 8.
10
Histopathological challenges in suspected drug-induced liver injury.疑似药物性肝损伤的组织病理学挑战。
Liver Int. 2018 Feb;38(2):198-209. doi: 10.1111/liv.13584. Epub 2017 Sep 19.